JP2008522604A - 敗血症の早期検出 - Google Patents

敗血症の早期検出 Download PDF

Info

Publication number
JP2008522604A
JP2008522604A JP2007544987A JP2007544987A JP2008522604A JP 2008522604 A JP2008522604 A JP 2008522604A JP 2007544987 A JP2007544987 A JP 2007544987A JP 2007544987 A JP2007544987 A JP 2007544987A JP 2008522604 A JP2008522604 A JP 2008522604A
Authority
JP
Japan
Prior art keywords
sepsis
analysis
data
clinical
neural network
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007544987A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008522604A5 (https=
Inventor
マシュー クリストファー ジャクソン
ローマン アントニー ルカソウスキー
アマンダ マリー イェイツ
マーティン ジュリアン ピアス
ティモシー ジョン ギルビー ブルックス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UK Secretary of State for Defence
Original Assignee
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UK Secretary of State for Defence filed Critical UK Secretary of State for Defence
Publication of JP2008522604A publication Critical patent/JP2008522604A/ja
Publication of JP2008522604A5 publication Critical patent/JP2008522604A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Theoretical Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Artificial Intelligence (AREA)
  • Databases & Information Systems (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Epidemiology (AREA)
  • Bioethics (AREA)
  • Evolutionary Computation (AREA)
  • Signal Processing (AREA)
JP2007544987A 2004-12-09 2005-12-09 敗血症の早期検出 Pending JP2008522604A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0426982.5A GB0426982D0 (en) 2004-12-09 2004-12-09 Early detection of sepsis
PCT/GB2005/004755 WO2006061644A1 (en) 2004-12-09 2005-12-09 Early detection of sepsis

Publications (2)

Publication Number Publication Date
JP2008522604A true JP2008522604A (ja) 2008-07-03
JP2008522604A5 JP2008522604A5 (https=) 2012-02-23

Family

ID=34073429

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007544987A Pending JP2008522604A (ja) 2004-12-09 2005-12-09 敗血症の早期検出

Country Status (8)

Country Link
US (1) US20080114576A1 (https=)
EP (2) EP1839218A1 (https=)
JP (1) JP2008522604A (https=)
CN (1) CN101076806B (https=)
AU (1) AU2005313114B2 (https=)
CA (1) CA2587270A1 (https=)
GB (1) GB0426982D0 (https=)
WO (1) WO2006061644A1 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140141534A (ko) * 2013-05-31 2014-12-10 가톨릭대학교 산학협력단 패혈증 고위험군 예측 방법 및 시스템
JP2016526888A (ja) * 2013-06-28 2016-09-08 アキュメン リサーチ ラボラトリーズ プライヴェット リミテッドＡｃｕｍｅｎ Ｒｅｓｅａｒｃｈ Ｌａｂｏｒａｔｏｒｉｅｓ Ｐｔｅ． Ｌｔｄ． 敗血症バイオマーカー及びそれらの使用
KR20200114975A (ko) * 2019-03-29 2020-10-07 연세대학교 산학협력단 균혈증 발병 위험도 예측 방법 및 이를 이용한 균혈증 발병 위험도 예측용 디바이스
JP2022540159A (ja) * 2019-07-12 2022-09-14 ベックマン コールター， インコーポレイテッド 収縮期血圧、血液パラメーター、およびこれらの組み合わせを含むバイタルサインを使用して敗血症を検出する方法

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9053222B2 (en) 2002-05-17 2015-06-09 Lawrence A. Lynn Patient safety processor
US8068990B2 (en) * 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
JP2008538007A (ja) 2005-04-15 2008-10-02 ベクトン，ディッキンソン アンド カンパニー 敗血症の診断
ES2349691T3 (es) * 2005-11-25 2011-01-10 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin PROCEDIMIENTO PARA DETECTAR O MONITORIZAR LA SEPTICEMIA ANALIZANDO NIVELES DE EXPRESIÓN DE ARNm DE CITOCINAS.
US8295392B2 (en) 2005-12-14 2012-10-23 Nec Corporation Digital communication system, indoor unit, and outdoor unit
GB0610078D0 (en) * 2006-05-20 2006-06-28 Secr Defence Sepsis detection microarray
EP1950310A1 (en) * 2007-01-23 2008-07-30 Charite-Universitätsmedizin Berlin Method for risk prediction of a postoperative sepsis in a human
GB0722582D0 (en) * 2007-11-16 2007-12-27 Secr Defence Early detection of sepsis
US8669113B2 (en) 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis
US11728041B2 (en) * 2008-05-07 2023-08-15 Lawrence A. Lynn Real-time time series matrix pathophysiologic pattern processor and quality assessment method
CA2722773C (en) 2008-05-07 2015-07-21 Lawrence A. Lynn Medical failure pattern search engine
EP2166358A1 (en) * 2008-09-17 2010-03-24 Fundacio Institut de Recerca de l'Hospital Universitari Vall d'Hebron Differential diagnostic biomarkers of stroke mimicking conditions and methods of use thereof
US10460408B2 (en) * 2009-01-31 2019-10-29 Mayo Foundation For Medical Education And Research Presentation of critical patient data
JP5667353B2 (ja) * 2009-09-25 2015-02-12 シスメックス株式会社 血球計数装置、診断支援装置、診断支援方法及びコンピュータプログラム
WO2011116872A1 (en) * 2010-03-02 2011-09-29 Roche Diagnostics Gmbh Il-6 detection based early diagnosis and prediction of systemic inflammatory response syndrome and sepsis in asymptomatic patients
US9719842B2 (en) * 2010-07-06 2017-08-01 Norman A. Paradis Method for the discovery, validation and clinical application of multiplex biomarker algorithms based on optical, physical and/or electromagnetic patterns
CA2818887A1 (en) * 2010-11-26 2012-05-31 Immunexpress Pty Ltd Diagnostic and/or screening agents and uses therefor
WO2014068018A1 (en) * 2012-10-30 2014-05-08 Abbott Gmbh & Co.Kg Methods of prognosis and diagnosis of sepsis
US9953453B2 (en) 2012-11-14 2018-04-24 Lawrence A. Lynn System for converting biologic particle density data into dynamic images
US10354429B2 (en) 2012-11-14 2019-07-16 Lawrence A. Lynn Patient storm tracker and visualization processor
WO2014117165A1 (en) * 2013-01-28 2014-07-31 Vanderbilt University Method for differentiating sepsis and systemic inflammatory response syndrome (sirs)
US20140241602A1 (en) 2013-02-28 2014-08-28 Lawrence A. Lynn System for Presentation of Sequential Blood Laboratory Measurements to Image Recognition Systems
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
GB201402293D0 (en) * 2014-02-11 2014-03-26 Secr Defence Biomarker signatures for the prediction of onset of sepsis
CN106714671A (zh) * 2014-09-26 2017-05-24 索弗拉狄姆产品公司 用于手术后感染的早期检测的系统和方法
US10761093B2 (en) 2014-10-09 2020-09-01 Texas Tech University System Microdevice for cell separation utilizing activation phenotype
US10832134B2 (en) 2015-12-10 2020-11-10 Deepmind Technologies Limited Augmenting neural networks with external memory
EP3408773B1 (en) * 2016-01-28 2023-09-20 Beckman Coulter, Inc. Infection detection and differentiation systems and methods
SG11201807719SA (en) * 2016-03-23 2018-10-30 Peach Intellihealth Inc Use of clinical parameters for the prediction of sirs
US11994514B2 (en) * 2018-06-15 2024-05-28 Beckman Coulter, Inc. Method of determining sepsis in the presence of blast flagging
CN111374639A (zh) * 2018-12-28 2020-07-07 陈柏龄 败血症的菌种预测系统与方法
US20220299511A1 (en) * 2019-06-17 2022-09-22 The Broad Institute, Inc. Immune cell signature for bacterial sepsis
CN114222907B (zh) * 2019-08-06 2024-10-25 贝克曼库尔特有限公司 检测和报道中性粒细胞亚群
US20210059597A1 (en) * 2019-08-30 2021-03-04 Hill-Rom Services, Inc. Sepsis monitoring system
WO2021102776A1 (zh) * 2019-11-28 2021-06-03 北京肿瘤医院(北京大学肿瘤医院) 一种用于早期体腔内感染性并发症诊断的标记物及方法
EP4082028A4 (en) * 2019-12-27 2024-01-24 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Predicting and addressing severe disease in individuals with sepsis
JP7708769B2 (ja) * 2020-01-10 2025-07-15 プレノシス，インコーポレイテッド ストリーミングデータ環境のための時間依存トリガ
WO2021142479A1 (en) * 2020-01-10 2021-07-15 Prenosis, Inc. A tool for selecting relevant features in precision diagnostics
CN114167062B (zh) * 2020-09-10 2024-02-02 北京肿瘤医院(北京大学肿瘤医院) 一种用于早期腹腔内感染性并发症诊断的标记物及方法
TWI803893B (zh) * 2021-06-28 2023-06-01 中國醫藥大學 敗血症之人工智慧輔助醫療診斷方法及其系統
DE102022114248A1 (de) 2022-06-07 2023-12-07 TCC GmbH Verfahren sowie Vorhersagesystem zur Ermittlung der Eintrittswahrscheinlichkeit einer Sepsis eines Patienten

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000052472A1 (en) * 1999-03-01 2000-09-08 The Board Of Trustees Of The Leland Stanford Junior University Rapid assay for infection in small children
US20030207278A1 (en) * 2002-04-25 2003-11-06 Javed Khan Methods for analyzing high dimensional data for classifying, diagnosing, prognosticating, and/or predicting diseases and other biological states
WO2004043236A2 (en) * 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190872B1 (en) * 1994-05-06 2001-02-20 Gus J. Slotman Method for identifying and monitoring patients at risk for systemic inflammatory conditions and apparatus for use in this method
US6804551B2 (en) 1998-03-17 2004-10-12 University Of Virginia Patent Foundation Method and apparatus for the early diagnosis of subacute, potentially catastrophic illness
AU5900299A (en) * 1998-08-24 2000-03-14 Emory University Method and apparatus for predicting the onset of seizures based on features derived from signals indicative of brain activity
DE10155600B4 (de) * 2001-11-09 2009-08-27 Oligene Gmbh Nukleinsäure-Array
US20040038201A1 (en) * 2002-01-22 2004-02-26 Whitehead Institute For Biomedical Research Diagnostic and therapeutic applications for biomarkers of infection
MXPA05005073A (es) * 2002-11-12 2005-11-17 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
BR0316232A (pt) * 2002-11-12 2005-10-04 Becton Dickinson Co Métodos para determinar o estado de sepsia, para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo
US20050164238A1 (en) * 2003-09-29 2005-07-28 Biosite, Inc. Methods and compositions for the diagnosis of sepsis
TW200519384A (en) * 2003-12-12 2005-06-16 We Gene Technologies Inc Sepsis detection chip and fabricating method thereof and method of detecting sepsis
US20050196817A1 (en) * 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
GB0610078D0 (en) * 2006-05-20 2006-06-28 Secr Defence Sepsis detection microarray

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000052472A1 (en) * 1999-03-01 2000-09-08 The Board Of Trustees Of The Leland Stanford Junior University Rapid assay for infection in small children
US20030207278A1 (en) * 2002-04-25 2003-11-06 Javed Khan Methods for analyzing high dimensional data for classifying, diagnosing, prognosticating, and/or predicting diseases and other biological states
WO2004043236A2 (en) * 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL FUR ANASTHESIE UND INTENSIVBEHANDLUNG, vol. 11, JPN7011002300, 18 February 2004 (2004-02-18), pages 40 - 43, ISSN: 0001950639 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140141534A (ko) * 2013-05-31 2014-12-10 가톨릭대학교 산학협력단 패혈증 고위험군 예측 방법 및 시스템
KR101595784B1 (ko) 2013-05-31 2016-02-26 가톨릭대학교 산학협력단 패혈증 고위험군 예측 방법 및 시스템
JP2016526888A (ja) * 2013-06-28 2016-09-08 アキュメン リサーチ ラボラトリーズ プライヴェット リミテッドＡｃｕｍｅｎ Ｒｅｓｅａｒｃｈ Ｌａｂｏｒａｔｏｒｉｅｓ Ｐｔｅ． Ｌｔｄ． 敗血症バイオマーカー及びそれらの使用
KR20200114975A (ko) * 2019-03-29 2020-10-07 연세대학교 산학협력단 균혈증 발병 위험도 예측 방법 및 이를 이용한 균혈증 발병 위험도 예측용 디바이스
KR102287968B1 (ko) 2019-03-29 2021-08-09 연세대학교 산학협력단 균혈증 발병 위험도 예측 방법 및 이를 이용한 균혈증 발병 위험도 예측용 디바이스
JP2022540159A (ja) * 2019-07-12 2022-09-14 ベックマン コールター， インコーポレイテッド 収縮期血圧、血液パラメーター、およびこれらの組み合わせを含むバイタルサインを使用して敗血症を検出する方法
JP7657195B2 (ja) 2019-07-12 2025-04-04 ベックマン コールター， インコーポレイテッド 収縮期血圧、血液パラメーター、およびこれらの組み合わせを含むバイタルサインを使用して敗血症を検出する方法

Also Published As

Publication number Publication date
US20080114576A1 (en) 2008-05-15
WO2006061644A1 (en) 2006-06-15
AU2005313114B2 (en) 2012-01-19
CA2587270A1 (en) 2006-06-15
CN101076806A (zh) 2007-11-21
GB0426982D0 (en) 2005-01-12
EP2458517A1 (en) 2012-05-30
AU2005313114A1 (en) 2006-06-15
EP1839218A1 (en) 2007-10-03
CN101076806B (zh) 2012-01-11

Similar Documents

Publication Publication Date Title
CN101076806B (zh) 败血症的早期检测
Sweeney et al. Benchmarking sepsis gene expression diagnostics using public data
Darden et al. Single-cell RNA-seq of human myeloid-derived suppressor cells in late sepsis reveals multiple subsets with unique transcriptional responses: a pilot study
CN106103744B (zh) 用于预测脓毒症发作的设备、试剂盒和方法
Sparks et al. A unified metric of human immune health
Sweeney et al. Risk stratification and prognosis in sepsis: what have we learned from microarrays?
Brakenridge et al. A transcriptomic severity metric that predicts clinical outcomes in critically ill surgical sepsis patients
Choi et al. Development and validation of an artificial intelligence model for the early classification of the aetiology of meningitis and encephalitis: a retrospective observational study
Buturovic et al. A 6-mRNA host response classifier in whole blood predicts outcomes in COVID-19 and other acute viral infections
Potti et al. Gene-expression patterns predict phenotypes of immune-mediated thrombosis
Cahill et al. Multiplexed plasma immune mediator signatures can differentiate sepsis from NonInfective SIRS: American Surgical Association 2020 annual meeting paper
Jukema et al. Point-of-care neutrophil and monocyte surface markers differentiate bacterial from viral infections at the emergency department within 30 min
WO2009063249A2 (en) Early detection of sepsis
TW202500757A (zh) 血漿中微生物片段之分析
Papantonopoulos et al. Aggressive periodontitis defined by recursive partitioning analysis of immunologic factors
Emgård et al. Distinct MAIT cell phenotypes associated with sepsis clinical outcome in emergency department patients
Tang et al. Monocyte single cell-type gene expression measured in peripheral blood by DIRECT LS-TA method: the ratio-based biomarkers of (IFI27/PSAP) showed superior performance than interferon score in triage patients with viral infection
Tang et al. Direct single cell-type gene expression analysis in Whole blood: Novel ratio-based gene expression biomarkers using 2 novel monocyte reference genes (PSAP and CTSS) for monitoring bacterial infection
ElAbd et al. Seq2MAIT: a novel deep learning framework for identifying Mucosal Associated Invariant T (MAIT) Cells
Saluja et al. SPARC scoring model: Objective outcome prediction in critically ill COVID-19 patients
Tang et al. In-silico cell sorting revealed granulocyte-specific single-cell-type gene expression from peripheral blood bulk expression data and its application as host response biomarkers to discriminate bacterial and viral infections
Arend et al. A Systematic Comparison of Differential Analysis Methods for CyTOF Data
WO2025184472A1 (en) Plasma cell-free rna signatures of inflammatory syndromes in children
WO2024119057A2 (en) Plasma cell-free rna signatures of tuberculosis
TW202536192A (zh) 用於疾病分類之微生物ｄｎａ分析

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081106

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110627

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110912

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110920

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20111227

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120625